[go: up one dir, main page]

FR2959510B1 - Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques - Google Patents

Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques

Info

Publication number
FR2959510B1
FR2959510B1 FR1053277A FR1053277A FR2959510B1 FR 2959510 B1 FR2959510 B1 FR 2959510B1 FR 1053277 A FR1053277 A FR 1053277A FR 1053277 A FR1053277 A FR 1053277A FR 2959510 B1 FR2959510 B1 FR 2959510B1
Authority
FR
France
Prior art keywords
pyrido
processes
preparation
therapeutic uses
pyrimidine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1053277A
Other languages
English (en)
Other versions
FR2959510A1 (fr
Inventor
Sylvain Routier
Gerald Guillaumet
Abdellatif Tikad
Oussama Dehbi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite d Orleans UFR de Sciences
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite d Orleans UFR de Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite d Orleans UFR de Sciences filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1053277A priority Critical patent/FR2959510B1/fr
Priority to US13/695,001 priority patent/US20130109693A1/en
Priority to PCT/FR2011/050959 priority patent/WO2011135259A1/fr
Publication of FR2959510A1 publication Critical patent/FR2959510A1/fr
Application granted granted Critical
Publication of FR2959510B1 publication Critical patent/FR2959510B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1053277A 2010-04-28 2010-04-28 Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques Expired - Fee Related FR2959510B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1053277A FR2959510B1 (fr) 2010-04-28 2010-04-28 Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques
US13/695,001 US20130109693A1 (en) 2010-04-28 2011-04-28 Derivatives of pyrido [3,2-d] pyrimidine, methods for preparation thereof and therapeutic uses thereof
PCT/FR2011/050959 WO2011135259A1 (fr) 2010-04-28 2011-04-28 Dérivés de pyrido[3,2-d]pyrimidine, leurs procédés de préparation et leurs utilisations thérapeutiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1053277A FR2959510B1 (fr) 2010-04-28 2010-04-28 Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques

Publications (2)

Publication Number Publication Date
FR2959510A1 FR2959510A1 (fr) 2011-11-04
FR2959510B1 true FR2959510B1 (fr) 2013-04-26

Family

ID=42745002

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1053277A Expired - Fee Related FR2959510B1 (fr) 2010-04-28 2010-04-28 Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques

Country Status (3)

Country Link
US (1) US20130109693A1 (fr)
FR (1) FR2959510B1 (fr)
WO (1) WO2011135259A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10192217B1 (en) 2012-04-25 2019-01-29 Wells Fargo Bank, N.A. System and method for receipt tracking in a mobile wallet
US10235668B1 (en) 2012-04-25 2019-03-19 Wells Fargo Bank, N.A. System and method for a mobile wallet
FR2994572B1 (fr) * 2012-08-17 2015-04-17 Centre Nat Rech Scient Pyrido[3,2-d]pyrimidines trisubstituees, leurs procedes de preparation et leurs utilisation en therapeutique
US20170050936A1 (en) 2013-08-23 2017-02-23 Neupharma, Inc. Certain chemical entities, compositions, and methods
CN107613769A (zh) 2015-02-17 2018-01-19 润新生物公司 某些化学实体、组合物和方法
EP3722297A1 (fr) 2015-03-04 2020-10-14 Gilead Sciences, Inc. Composés modulateurs de récepteurs de type toll
WO2018035061A1 (fr) 2016-08-15 2018-02-22 Neupharma, Inc. Entités chimiques, compositions et méthodes particulières
ES2906581T3 (es) 2016-09-02 2022-04-19 Gilead Sciences Inc Compuestos moduladores de los receptores tipo Toll
US10640499B2 (en) 2016-09-02 2020-05-05 Gilead Sciences, Inc. Toll like receptor modulator compounds
GB201700814D0 (en) 2017-01-17 2017-03-01 Liverpool School Tropical Medicine Compounds
FR3066761B1 (fr) 2017-05-23 2020-10-30 Centre Nat Rech Scient Nouveaux composes inhibiteurs des canaux ioniques
EP3822271A4 (fr) * 2018-07-03 2022-04-13 Jiangsu Hengrui Medicine Co., Ltd. Dérivé de pyridopyrimidine, son procédé de préparation et son utilisation médicale
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1899332A1 (fr) * 2005-06-24 2008-03-19 Gilead Sciences, Inc. Pyrido(3,2-d)pyrimidines et compositions pharmaceutiques destinees au traitement de l'hepatite c
CA2661436A1 (fr) * 2006-08-24 2008-02-28 Serenex, Inc. Derives d'isoquinoline, quinazoline et phtalazine

Also Published As

Publication number Publication date
FR2959510A1 (fr) 2011-11-04
WO2011135259A1 (fr) 2011-11-03
US20130109693A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
FR2959510B1 (fr) Derives de pyrido[3,2-d]pyrimidine, leurs procedes de preparation et leurs utilisations therapeutiques
EP2600719A4 (fr) 8-alkyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitriles substitués en 2 et leurs utilisations
EP2770994A4 (fr) 1h-pyrazolo[3,4-b]pyridines et leurs utilisations thérapeutiques
IL229863A0 (en) The history of pyrimidine and pyridine, their preparation and pharmaceutical preparations containing them
FR2962438B1 (fr) Derives d'indolizines, procedes de preparation et application en therapeutique
ZA201405070B (en) 1h-pyrrolo[2,3-b] pyridine derivatives and their use as kinase inhibitors
IL238493B (en) Amino-substituted imidazo[a–2,1]pyridinecarboxamides and their use
SI3447061T1 (sl) Farmacevtska formulacija, ki obsega fosforamidni derivat 5-fluoro-2'-deoksiuridina za uporabo pri zdravljenju raka
IL229528A0 (en) History of pyridine and pyrazine, their preparation and use
FR2988722B1 (fr) Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques
ZA201307511B (en) Pyrido [2,3-b] pyrazine derivatives and their therapeutical uses
ZA201406323B (en) Triazolo[4,5-d]pyrimidine derivatives
IL232717A0 (en) 3-cyanoaryl-h1-pyrrolo[b-3,2]pyridine derivatives
IL236121A0 (en) Pyrimidinone derivatives as antimalarials
EP2512250A4 (fr) Pyrido[2,3-d]pyrimidin-7(8h)-ones substitués et leurs utilisations thérapeuthiques
FR2943057B1 (fr) DERIVES DE 10-AMINO-1,2,3,4-TETRAHYDROPYRIDO°2,1-a!ISOINDOL-6(10bH)- ONES, LEUR PROCEDE DE PREPARATION ET LEURS UTILISATIONS THERAPEUTIQUES
ZA201307085B (en) Thieno [2,3-d] pyrimidine derivatives and their use to treat arrhythmia
EP2639235A4 (fr) Dérivé de pyrazino[2,3-d]isooxazole
FR2967672B1 (fr) Derives de nitrobenzothiazoles, leur preparation et leurs applications therapeutiques
FR2976943B1 (fr) Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance
FR2976942B1 (fr) Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance
FR2994572B1 (fr) Pyrido[3,2-d]pyrimidines trisubstituees, leurs procedes de preparation et leurs utilisation en therapeutique
FR2976287B1 (fr) Derives benzoquinolizidines, leur procede de preparation et leurs applications en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20151231